Ken Griffin Morphic Holding, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 4,200 shares of MORF stock, worth $239,358. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,200

Previous 4,700 10.64%

Holding current value

$239,358

Previous $165,000 13.33%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$26.12 - $34.07 $18.4 Million - $24 Million	-704,910 Reduced 81.31%	161,988 $5.52 Million
Q1 2024 May 15, 2024	BUY	$26.64 - $40.31 $20.3 Million - $30.8 Million	763,361 Added 737.28%	866,898 $30.5 Million
Q4 2023 Feb 14, 2024	SELL	$19.95 - $31.0 $8.34 Million - $13 Million	-417,808 Reduced 80.14%	103,537 $2.99 Million
Q3 2023 Nov 14, 2023	BUY	$21.33 - $59.42 $11.1 Million - $31 Million	521,345 New	521,345 $11.9 Million
Q1 2023 May 15, 2023	SELL	$26.01 - $48.69 $5.72 Million - $10.7 Million	-219,835 Reduced 55.53%	176,075 $6.63 Million
Q4 2022 Feb 14, 2023	SELL	$24.14 - $30.37 $178,467 - $224,525	-7,393 Reduced 1.83%	395,910 $10.6 Million
Q3 2022 Nov 14, 2022	BUY	$22.23 - $33.37 $8 Million - $12 Million	360,012 Added 831.61%	403,303 $11.4 Million
Q2 2022 Aug 15, 2022	SELL	$19.74 - $43.01 $939,860 - $2.05 Million	-47,612 Reduced 52.38%	43,291 $939,000
Q1 2022 May 16, 2022	BUY	$36.25 - $52.02 $1.62 Million - $2.32 Million	44,610 Added 96.36%	90,903 $3.65 Million
Q3 2021 Nov 15, 2021	BUY	$53.61 - $67.5 $1.05 Million - $1.32 Million	19,502 Added 72.79%	46,293 $2.62 Million
Q1 2021 May 17, 2021	SELL	$29.77 - $84.85 $1.7 Million - $4.83 Million	-56,949 Reduced 68.01%	26,791 $1.7 Million
Q4 2020 Feb 16, 2021	BUY	$25.66 - $34.55 $743,934 - $1 Million	28,992 Added 52.96%	83,740 $2.81 Million
Q3 2020 Nov 16, 2020	BUY	$22.51 - $30.11 $158,560 - $212,094	7,044 Added 14.77%	54,748 $1.5 Million
Q2 2020 Aug 14, 2020	SELL	$12.65 - $29.57 $26,425 - $61,771	-2,089 Reduced 4.2%	47,704 $1.29 Million
Q1 2020 May 15, 2020	SELL	$10.84 - $20.85 $342,836 - $659,422	-31,627 Reduced 38.84%	49,793 $731,000
Q2 2019 Aug 14, 2019	BUY	$18.0 - $19.82 $1.47 Million - $1.61 Million	81,420 New	81,420 $1.61 Million

Others Institutions Holding MORF

# of Institutions

140

Shares Held

38.7M

Call Options Held

4.2K

Put Options Held

200K

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account